PURPOSE: This study aimed to describe the perceptions of women with early stage breast cancer regarding their involvement in treatment decision making (TDM). METHODS: Eligible women with early stage breast cancer were recruited immediately after their first consultation with a specialist. Semistructured personal interviews were held prior to treatment. Interviews were audiotaped, transcribed, and analyzed. RESULTS: Nineteen women with early stage breast cancer considering surgery (n = 6) or adjuvant therapy (n = 13) participated. Women described being involved in various stages of TDM and interacting with informal networks and specialists. Women's descriptions suggest that (1) the concept of involvement in TDM may have a broader meaning for patients than strictly their decisional role and (2) inclusion of significant others in TDM contributes to the patient's sense of involvement. CONCLUSIONS: Conceptualization and measurement of patient involvement in TDM have often been framed within the context of the medical encounter and the patient's perceived or actual role in this process. Our findings raise questions about what involvement means to patients with early stage breast cancer and suggest that the focus on patient involvement in TDM within the medical encounter may be too narrow to capture the meaning of involvement from the patient's perspective.
PURPOSE: This study aimed to describe the perceptions of women with early stage breast cancer regarding their involvement in treatment decision making (TDM). METHODS: Eligible women with early stage breast cancer were recruited immediately after their first consultation with a specialist. Semistructured personal interviews were held prior to treatment. Interviews were audiotaped, transcribed, and analyzed. RESULTS: Nineteen women with early stage breast cancer considering surgery (n = 6) or adjuvant therapy (n = 13) participated. Women described being involved in various stages of TDM and interacting with informal networks and specialists. Women's descriptions suggest that (1) the concept of involvement in TDM may have a broader meaning for patients than strictly their decisional role and (2) inclusion of significant others in TDM contributes to the patient's sense of involvement. CONCLUSIONS: Conceptualization and measurement of patient involvement in TDM have often been framed within the context of the medical encounter and the patient's perceived or actual role in this process. Our findings raise questions about what involvement means to patients with early stage breast cancer and suggest that the focus on patient involvement in TDM within the medical encounter may be too narrow to capture the meaning of involvement from the patient's perspective.
Authors: Gillian Spiegle; Eisar Al-Sukhni; Selina Schmocker; Anna R Gagliardi; J Charles Victor; Nancy N Baxter; Erin D Kennedy Journal: Cancer Date: 2012-07-18 Impact factor: 6.860
Authors: Mary Ann O'Brien; Peter M Ellis; Timothy J Whelan; Cathy Charles; Amiram Gafni; Peter Lovrics; Som D Mukherjee; Nicole Hodgson Journal: Health Expect Date: 2011-09-16 Impact factor: 3.377
Authors: Mary Ann O'Brien; Timothy J Whelan; Miguel Villasis-Keever; Amiram Gafni; Cathy Charles; Robin Roberts; Susan Schiff; Wenjie Cai Journal: J Clin Oncol Date: 2009-01-05 Impact factor: 44.544
Authors: Gabrielle B Rocque; Aysha Rasool; Beverly R Williams; Audrey S Wallace; Soumya J Niranjan; Karina I Halilova; Yasemin E Turkman; Stacey A Ingram; Courtney P Williams; Andres Forero-Torres; Tom Smith; Smita Bhatia; Sara J Knight Journal: Oncologist Date: 2019-03-14
Authors: Nicholas Zdenkowski; Phyllis Butow; Elizabeth Hutchings; Charles Douglas; Joseph R Coll; Frances M Boyle Journal: JMIR Res Protoc Date: 2016-05-20